These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26481540)

  • 1. Effect of a kynurenic acid analog on home-cage activity and body temperature in rats.
    Kassai F; Kedves R; Gyertyán I; Tuka B; Fülöp F; Toldi J; Lendvai B; Vécsei L
    Pharmacol Rep; 2015 Dec; 67(6):1188-92. PubMed ID: 26481540
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kynurenic Acid and Its Analogue SZR-72 Ameliorate the Severity of Experimental Acute Necrotizing Pancreatitis.
    Balla Z; Kormányos ES; Kui B; Bálint ER; Fűr G; Orján EM; Iványi B; Vécsei L; Fülöp F; Varga G; Harazin A; Tubak V; Deli MA; Papp C; Gácser A; Madácsy T; Venglovecz V; Maléth J; Hegyi P; Kiss L; Rakonczay Z
    Front Immunol; 2021; 12():702764. PubMed ID: 34745090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kynurenic Acid and Its Synthetic Derivatives Protect Against Sepsis-Associated Neutrophil Activation and Brain Mitochondrial Dysfunction in Rats.
    Poles MZ; Nászai A; Gulácsi L; Czakó BL; Gál KG; Glenz RJ; Dookhun D; Rutai A; Tallósy SP; Szabó A; Lőrinczi B; Szatmári I; Fülöp F; Vécsei L; Boros M; Juhász L; Kaszaki J
    Front Immunol; 2021; 12():717157. PubMed ID: 34475875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The kynurenate analog SZR-72 prevents the nitroglycerol-induced increase of c-fos immunoreactivity in the rat caudal trigeminal nucleus: comparative studies of the effects of SZR-72 and kynurenic acid.
    Knyihar-Csillik E; Mihaly A; Krisztin-Peva B; Robotka H; Szatmari I; Fulop F; Toldi J; Csillik B; Vecsei L
    Neurosci Res; 2008 Aug; 61(4):429-32. PubMed ID: 18541319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparative assessment of two kynurenic acid analogs in the formalin model of trigeminal activation: a behavioral, immunohistochemical and pharmacokinetic study.
    Veres G; Fejes-Szabó A; Zádori D; Nagy-Grócz G; László AM; Bajtai A; Mándity I; Szentirmai M; Bohár Z; Laborc K; Szatmári I; Fülöp F; Vécsei L; Párdutz Á
    J Neural Transm (Vienna); 2017 Jan; 124(1):99-112. PubMed ID: 27629500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioural studies with a newly developed neuroprotective KYNA-amide.
    Gellért L; Varga D; Ruszka M; Toldi J; Farkas T; Szatmári I; Fülöp F; Vécsei L; Kis Z
    J Neural Transm (Vienna); 2012 Feb; 119(2):165-72. PubMed ID: 21818601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analog of kynurenic acid decreases tau pathology by modulating astrogliosis in rat model for tauopathy.
    Majerova P; Olesova D; Golisova G; Buralova M; Michalicova A; Vegh J; Piestansky J; Bhide M; Hanes J; Kovac A
    Biomed Pharmacother; 2022 Aug; 152():113257. PubMed ID: 35714514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SZR-104, a Novel Kynurenic Acid Analogue with High Permeability through the Blood-Brain Barrier.
    Molnár K; Lőrinczi B; Fazakas C; Szatmári I; Fülöp F; Kmetykó N; Berkecz R; Ilisz I; Krizbai IA; Wilhelm I; Vécsei L
    Pharmaceutics; 2021 Jan; 13(1):. PubMed ID: 33466551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time-course of kynurenic acid concentration in mouse serum following the administration of a novel kynurenic acid analog.
    Zádori D; Ilisz I; Klivényi P; Szatmári I; Fülöp F; Toldi J; Vécsei L; Péter A
    J Pharm Biomed Anal; 2011 Jun; 55(3):540-3. PubMed ID: 21392919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divergent Effects of the N-Methyl-D-Aspartate Receptor Antagonist Kynurenic Acid and the Synthetic Analog SZR-72 on Microcirculatory and Mitochondrial Dysfunction in Experimental Sepsis.
    Juhász L; Rutai A; Fejes R; Tallósy SP; Poles MZ; Szabó A; Szatmári I; Fülöp F; Vécsei L; Boros M; Kaszaki J
    Front Med (Lausanne); 2020; 7():566582. PubMed ID: 33330526
    [No Abstract]   [Full Text] [Related]  

  • 11. Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease.
    Zádori D; Nyiri G; Szonyi A; Szatmári I; Fülöp F; Toldi J; Freund TF; Vécsei L; Klivényi P
    J Neural Transm (Vienna); 2011 Jun; 118(6):865-75. PubMed ID: 21194001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological effects of some kynurenic acid analogs.
    Nagy K; Plangár I; Tuka B; Gellért L; Varga D; Demeter I; Farkas T; Kis Z; Marosi M; Zádori D; Klivényi P; Fülöp F; Szatmári I; Vécsei L; Toldi J
    Bioorg Med Chem; 2011 Dec; 19(24):7590-6. PubMed ID: 22079867
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Opposite Effects of Kynurenic Acid and Different Kynurenic Acid Analogs on Tumor Necrosis Factor-α (TNF-α) Production and Tumor Necrosis Factor-Stimulated Gene-6 (TSG-6) Expression.
    Mándi Y; Endrész V; Mosolygó T; Burián K; Lantos I; Fülöp F; Szatmári I; Lőrinczi B; Balog A; Vécsei L
    Front Immunol; 2019; 10():1406. PubMed ID: 31316502
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparative study on the effects of kynurenic acid and glucosamine-kynurenic acid.
    Füvesi J; Somlai C; Németh H; Varga H; Kis Z; Farkas T; Károly N; Dobszay M; Penke Z; Penke B; Vécsei L; Toldi J
    Pharmacol Biochem Behav; 2004 Jan; 77(1):95-102. PubMed ID: 14724046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction.
    Klein C; Patte-Mensah C; Taleb O; Bourguignon JJ; Schmitt M; Bihel F; Maitre M; Mensah-Nyagan AG
    Neuropharmacology; 2013 Jul; 70():254-60. PubMed ID: 23422298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The neuroprotective actions of kynurenic acid and MK-801 in gerbils are synergistic and not related to hypothermia.
    Gill R; Woodruff GN
    Eur J Pharmacol; 1990 Feb; 176(2):143-9. PubMed ID: 2178948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-treatment with new kynurenic acid amide dose-dependently prevents the nitroglycerine-induced neuronal activation and sensitization in cervical part of trigemino-cervical complex.
    Fejes-Szabó A; Bohár Z; Vámos E; Nagy-Grócz G; Tar L; Veres G; Zádori D; Szentirmai M; Tajti J; Szatmári I; Fülöp F; Toldi J; Párdutz Á; Vécsei L
    J Neural Transm (Vienna); 2014 Jul; 121(7):725-38. PubMed ID: 24385076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paradox effects of kynurenines on LTP induction in the Wistar rat. An in vivo study.
    Demeter I; Nagy K; Farkas T; Kis Z; Kocsis K; Knapp L; Gellert L; Fülöp F; Vecsei L; Toldi J
    Neurosci Lett; 2013 Oct; 553():138-41. PubMed ID: 23978510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kynurenic acid and its derivatives are able to modulate the adhesion and locomotion of brain endothelial cells.
    Lajkó E; Tuka B; Fülöp F; Krizbai I; Toldi J; Magyar K; Vécsei L; Kőhidai L
    J Neural Transm (Vienna); 2018 Jun; 125(6):899-912. PubMed ID: 29332257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kynurenic acid modulates experimentally induced inflammation in the trigeminal ganglion.
    Csáti A; Edvinsson L; Vécsei L; Toldi J; Fülöp F; Tajti J; Warfvinge K
    J Headache Pain; 2015; 16():99. PubMed ID: 26627709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.